Summary — SB 2215 (Public Act 104-0413): Information Distribution on Ovarian Reserve and Fertility Options
Status and key dates
- Bill number: SB 2215 — Enrolled as Public Act 104-0413
- Governor approved: August 15, 2025
- Effective date: January 1, 2026
- Introduced: February/March 2025 (filed by Sen. Suzy Glowiak Hilton); passed both houses May 2025 and sent to Governor June 27, 2025.
Note: some header metadata in the materials (e.g., a “shoplifting” title and “Died in Committee” status) appear to be erroneous. The enrolled/enacted text concerns fertility information and the Department of Public Health.
Purpose and intent
- To require the Illinois Department of Public Health (DPH) to prepare and provide clinical, evidence-based informational materials about ovarian reserve and fertility assessment that health care professionals may distribute to women age 25+ and to women generally interested in future fertility. The aim is to improve patient understanding of factors affecting fertility and of available testing and resources.
Key provisions
- Adds Section 8.5 to the Department of Public Health Act (20 ILCS 2305/8.5).
- Defines “health care professional” to include physicians (Medical Practice Act), podiatrists, advanced practice registered nurses (APRNs), and physician assistants (PAs).
- Requires DPH to provide clinical, evidence-based information to health care professionals for distribution. Required content includes, at minimum:
1. A description of factors impacting fertility, including the concept of ovarian reserve;
2. An overview of different types of ovarian reserve testing (and in later amendments, the limitations of those tests);
3. Information on potential test results and resources available after testing (some versions also include a list of healthcare centers/hospitals that provide testing).
- Materials are informational—SB 2215 does not mandate testing, require clinicians to provide tests, or establish insurance coverage or penalties.
Who is affected
- Primary recipients: women age 25 and older and any women seeking information about future fertility.
- Intermediaries: health care professionals who may receive and distribute the DPH materials.
- Department of Public Health: responsible for developing and disseminating the materials; may incur administrative costs.
- Health care facilities: may see increased patient inquiries or demand for ovarian reserve testing or counseling.
Potential impacts and limitations
- Likely outcomes: improved patient knowledge and informed decision-making about ovarian reserve testing and fertility planning; possible increases in demand for testing and fertility counseling.
- Does not require coverage, testing, or clinical action—materials are advisory.
- No specific appropriation or funding mechanism is specified in the enacted text; development and dissemination are administrative responsibilities of DPH.
- Scope limited to information distribution; clinical decisions remain between patient and provider.
For further reference
- Enrolled text: Public Act 104-0413, Section adding 20 ILCS 2305/8.5. Effective January 1, 2026.
